Beech Hill Advisors, Inc. Exact Sciences Corp Transaction History

Beech Hill Advisors, Inc.

$240 Million
Q1 2025

A detailed history of Beech Hill Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Beech Hill Advisors, Inc. holds 59,911 shares of EXAS stock, worth $3.26 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

59,911

Previous 46,435 29.02%

Holding current value

$3.26 Million

Previous $2.61 Million 0.61%

% of portfolio

1.08%

Previous 1.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	BUY	$43.04 - $58.51 $580,007 - $788,480	13,476 Added 29.02%	59,911 $2.59 Million
Q4 2024 Jan 14, 2025	SELL	$49.33 - $71.97 $561,523 - $819,234	-11,383 Reduced 19.69%	46,435 $2.61 Million
Q3 2024 Oct 16, 2024	SELL	$42.43 - $70.83 $77,604 - $129,548	-1,829 Reduced 3.07%	57,818 $3.94 Million
Q2 2024 Jul 12, 2024	BUY	$41.33 - $74.26 $327,994 - $589,327	7,936 Added 15.35%	59,647 $2.52 Million
Q1 2024 Apr 12, 2024	BUY	$56.27 - $73.77 $21,720 - $28,475	386 Added 0.75%	51,711 $3.57 Million
Q4 2023 Jan 10, 2024	BUY	$59.06 - $75.72 $97,153 - $124,559	1,645 Added 3.31%	51,325 $3.8 Million
Q3 2023 Oct 10, 2023	BUY	$65.94 - $99.04 $157,530 - $236,606	2,389 Added 5.05%	49,680 $3.39 Million
Q2 2023 Jul 10, 2023	SELL	$62.68 - $95.05 $133,195 - $201,981	-2,125 Reduced 4.3%	47,291 $4.44 Million
Q1 2023 Apr 14, 2023	SELL	$47.19 - $70.77 $70,313 - $105,447	-1,490 Reduced 2.93%	49,416 $3.35 Million
Q4 2022 Jan 17, 2023	SELL	$30.35 - $53.15 $483,627 - $846,945	-15,935 Reduced 23.84%	50,906 $0
Q3 2022 Oct 12, 2022	BUY	$31.97 - $49.37 $663,537 - $1.02 Million	20,755 Added 45.04%	66,841 $2.17 Million
Q2 2022 Jul 11, 2022	SELL	$35.61 - $76.23 $76,027 - $162,751	-2,135 Reduced 4.43%	46,086 $1.82 Million
Q1 2022 Apr 19, 2022	BUY	$57.56 - $82.54 $1.9 Million - $2.72 Million	32,930 Added 215.36%	48,221 $3.37 Million
Q4 2021 Jan 19, 2022	SELL	$72.5 - $100.68 $1.51 Million - $2.1 Million	-20,835 Reduced 57.67%	15,291 $1.19 Million
Q3 2021 Oct 14, 2021	BUY	$90.24 - $124.05 $262,147 - $360,365	2,905 Added 8.74%	36,126 $3.45 Million
Q2 2021 Jul 15, 2021	BUY	$93.66 - $139.27 $207,175 - $308,065	2,212 Added 7.13%	33,221 $4.13 Million
Q1 2021 Apr 19, 2021	BUY	$116.57 - $155.01 $99,550 - $132,378	854 Added 2.83%	31,009 $4.09 Million
Q4 2020 Jan 22, 2021	SELL	$99.61 - $142.12 $39,844 - $56,848	-400 Reduced 1.31%	30,155 $4 Million
Q3 2020 Oct 19, 2020	BUY	$72.92 - $102.01 $134,537 - $188,208	1,845 Added 6.43%	30,555 $3.12 Million
Q2 2020 Jul 17, 2020	BUY	$55.75 - $92.75 $9,756 - $16,231	175 Added 0.61%	28,710 $2.5 Million
Q1 2020 May 05, 2020	BUY	$37.9 - $104.44 $1.08 Million - $2.98 Million	28,535 New	28,535 $1.66 Million

Others Institutions Holding EXAS

# of Institutions

645

Shares Held

157M

Call Options Held

1.74M

Put Options Held

1.56M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.62B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beech Hill Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beech Hill Advisors, Inc. with notifications on news.

Account

Beech Hill Advisors, Inc. Exact Sciences Corp Transaction History